1. Home
  2. POLA vs MIRA Comparison

POLA vs MIRA Comparison

Compare POLA & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

N/A

Current Price

$1.27

Market Cap

6.0M

Sector

Miscellaneous

ML Signal

N/A

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$0.73

Market Cap

32.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POLA
MIRA
Founded
1979
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
32.1M
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
POLA
MIRA
Price
$1.27
$0.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
125.1K
1.6M
Earning Date
04-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,801,141.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.14
N/A
52 Week Low
$1.26
$0.60
52 Week High
$5.70
$2.45

Technical Indicators

Market Signals
Indicator
POLA
MIRA
Relative Strength Index (RSI) 32.94 45.11
Support Level N/A $0.72
Resistance Level $1.93 $0.82
Average True Range (ATR) 0.06 0.08
MACD -0.01 0.00
Stochastic Oscillator 10.35 8.29

Price Performance

Historical Comparison
POLA
MIRA

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Other Asia Pacific, Europe and Middle East, United Kingdom, and South Africa.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: